PBK and malignant colon neoplasm: HI-TOPK-032, one of the TOPK inhibitors, was shown to inhibit tumor growth by nearly 50% in a HCT116 colon cancer cell-derived xenograft mouse model at a dose of 10 mg/kg (Kim et al., 2012).